Journal of Hepatology
Volume 52, Issue 2 , Pages 153-159 , February 2010

Lower copy numbers of the chemokine CCL3L1 gene in patients with chronic hepatitis C

  • Frank Grünhage

      Affiliations

    • Department of Medicine II, Saarland University Hospital, Saarland University, Kirrberger Str. 1, 68421 Homburg, Germany
    • Corresponding Author InformationCorresponding author. Tel.: +49 684 11623202; fax: +49 6841 1623267.
    • These authors contributed equally.
    • ,
  • Jacob Nattermann

      Affiliations

    • Department of Internal Medicine I, University Hospital Bonn, University of Bonn, Bonn, Germany
    • These authors contributed equally.
    • ,
  • Olav A. Gressner

      Affiliations

    • Department of Internal Medicine I, University Hospital Bonn, University of Bonn, Bonn, Germany
    • Institute of Clinical Chemistry and Pathobiochemistry and Central Laboratory, RWTH-University Hospital, Aachen, Germany
    • ,
  • Hermann E. Wasmuth

      Affiliations

    • Department of Medicine III, University Hospital Aachen, Aachen University (RWTH), Germany
    • ,
  • Claus Hellerbrand

      Affiliations

    • Department of Medicine I, University Hospital Regensburg, University of Regensburg, Germany
    • ,
  • Tilman Sauerbruch

      Affiliations

    • Department of Internal Medicine I, University Hospital Bonn, University of Bonn, Bonn, Germany
    • ,
  • Ulrich Spengler

      Affiliations

    • Department of Internal Medicine I, University Hospital Bonn, University of Bonn, Bonn, Germany
    • ,
  • Frank Lammert

      Affiliations

    • Department of Medicine II, Saarland University Hospital, Saarland University, Kirrberger Str. 1, 68421 Homburg, Germany

Received 5 February 2009 ,Revised 2 August 2009 ,Accepted 1 September 2009.

References 

  1. Bataller R, North KE, Brenner DA. Genetic polymorphisms and the progression of liver fibrosis: a critical appraisal. Hepatology. 2003;37:493–503
  2. Asselah T, Bieche I, Paradis V, Bedossa P, Vidaud M, Marcellin P. Genetics, genomics, and proteomics: implications for the diagnosis and the treatment of chronic hepatitis C. Semin Liver Dis. 2007;27:13–27
  3. Redon R, Ishikawa S, Fitch KR, Feuk L, Perry GH, Andrews TD, et al. Global variation in copy number in the human genome. Nature. 2006;444:444–454
  4. Abecasis G, Tam PK, Bustamante CD, Ostrander EA, Scherer SW, Chanock SJ, et al. Human genome variation 2006: emerging views on structural variation and large-scale SNP analysis. Nat Genet. 2007;39:153–155
  5. Jakobsson M, Scholz SW, Scheet P, Gibbs JR, VanLiere JM, Fung HC, et al. Genotype, haplotype and copy-number variation in worldwide human populations. Nature. 2008;451:998–1003
  6. Feuk L, Carson AR, Scherer SW. Structural variation in the human genome. Nat Rev Genet. 2006;7:85–97
  7. Cotton RG. Recommendations of the 2006 Human Variome Project meeting. Nat Genet. 2007;39:433–436
  8. Beckmann JS, Estivill X, Antonarakis SE. Copy number variants and genetic traits: closer to the resolution of phenotypic to genotypic variability. Nat Rev Genet. 2007;8:639–646
  9. Gonzalez E, Kulkarni H, Bolivar H, Mangano A, Sanchez R, Catano G, et al. The influence of CCL3L1 gene-containing segmental duplications on HIV-1/AIDS susceptibility. Science. 2005;307:1434–1440
  10. Aitman TJ, Dong R, Vyse TJ, Norsworthy PJ, Johnson MD, Smith J, et al. Copy number polymorphism in Fcgr3 predisposes to glomerulonephritis in rats and humans. Nature. 2006;439:851–855
  11. Fellermann K, Stange DE, Schaeffeler E, Schmalzl H, Wehkamp J, Bevins CL, et al. A chromosome 8 gene-cluster polymorphism with low human beta-defensin 2 gene copy number predisposes to Crohn disease of the colon. Am J Hum Genet. 2006;79:439–448
  12. Sebat J, Lakshmi B, Malhotra D, Troge J, Lese-Martin C, Walsh T, et al. Strong association of de novo copy number mutations with autism. Science. 2007;316:445–449
  13. Thorleifsson G, Walters GB, Gudbjartsson DF, Steinthorsdottir V, Sulem P, Helgadottir A, et al. Genome-wide association yields new sequence variants at seven loci that associate with measures of obesity. Nat Genet. 2009;41:18–24
  14. Spada E, Mele A, Berton A, Ruggeri L, Ferrigno L, Garbuglia AR, et al. Multispecific T cell response and negative HCV RNA tests during acute HCV infection are early prognostic factors of spontaneous clearance. Gut. 2004;53:1673–1681
  15. Thimme R, Neumann-Haefelin C. Genetics in viral hepatitis: role of HLA class I and II alleles in hepatitis C virus infection. In: Blum HE, Cox DW, Häussinger D, Jansen PL, Kullak-Ublick GA, editors. Genetics in liver diseases. Dordrecht: Springer; 2007. p. 18–31.
  16. Charo IF, Ransohoff RM. The many roles of chemokines and chemokine receptors in inflammation. N Engl J Med. 2006;354:610–621
  17. Heydtmann M, Adams DH. Chemokines in the immunopathogenesis of hepatitis C infection. Hepatology. 2009;49:676–688
  18. Combadiere C, Ahuja SK, Tiffany HL, Murphy PM. Cloning and functional expression of CC CKR5, a human monocyte CC chemokine receptor selective for MIP-1alpha, MIP-1beta, and RANTES. J Leukoc Biol. 1996;60:147–152
  19. Luster AD. Chemokines–chemotactic cytokines that mediate inflammation. N Engl J Med. 1998;338:436–445
  20. Menten P, Wuyts A, van Damme J. Macrophage inflammatory protein-1. Cytokine Growth Factor Rev. 2002;13:455–481
  21. Ahuja SK, Kulkarni H, Catano G, Agan BK, Camargo JF, He W, et al. CCL3L1-CCR5 genotype influences durability of immune recovery during antiretroviral therapy of HIV-1-infected individuals. Nat Med. 2008;14:413–420
  22. Woitas RP, Ahlenstiel G, Iwan A, Rockstroh JK, Brackmann HH, Kupfer B, et al. Frequency of the HIV-protective CC chemokine receptor 5-Delta32/Delta32 genotype is increased in hepatitis C. Gastroenterology. 2002;122:1721–1728
  23. Promrat K, McDermott DH, Gonzalez CM, Kleiner DE, Koziol DE, Lessie M, et al. Associations of chemokine system polymorphisms with clinical outcomes and treatment responses of chronic hepatitis C. Gastroenterology. 2003;124:352–360
  24. Wald O, Pappo O, Ari ZB, Azzaria E, Wiess ID, Gafnovitch I, et al. The CCR5Delta32 allele is associated with reduced liver inflammation in hepatitis C virus infection. Eur J Immunogenet. 2004;31:249–252
  25. Wasmuth HE, Werth A, Mueller T, Berg T, Dietrich CG, Geier A, et al. CC chemokine receptor 5 Delta32 polymorphism in two independent cohorts of hepatitis C virus infected patients without hemophilia. J Mol Med. 2004;82:64–69
  26. Rockstroh JK, Spengler U. HIV and hepatitis C virus co-infection. Lancet Infect Dis. 2004;4:437–444
  27. Ahlenstiel G, Nischalke HD, Bueren K, Berg T, Vogel M, Biermer M, et al. The GNB3 C825T polymorphism affects response to HCV therapy with pegylated interferon in HCV/HIV co-infected but not in HCV mono-infected patients. J Hepatol. 2007;47:348–355
  28. Woodall WH. The use of control charts in health-care and public-health surveillance. J Quality Technol. 2006;38:89–104
  29. Desmet VJ, Gerber M, Hoofnagle JH, Manns M, Scheuer PJ. Classification of chronic hepatitis: diagnosis, grading and staging. Hepatology. 1994;19:1513–1520
  30. Shao W, Tang J, Song W, Wang C, Li Y, Wilson CM, et al. CCL3L1 and CCL4L1: variable gene copy number in adolescents with and without human immunodeficiency virus type 1 (HIV-1) infection. Genes Immun. 2007;8:224–231
  31. McKinney C, Merriman ME, Chapman PT, Gow PJ, Harrison AA, Highton J, et al. Evidence for an influence of chemokine ligand 3-like 1 (CCL3L1) gene copy number on susceptibility to rheumatoid arthritis. Ann Rheum Dis. 2008;67:409–413
  32. Townson JR, Barcellos LF, Nibbs RJ. Gene copy number regulates the production of the human chemokine CCL3–L1. Eur J Immunol. 2002;32:3016–3026
  33. McCarroll SA, Altshuler DM. Copy-number variation and association studies of human disease. Nat Genet. 2007;39:S37–S42
  34. Lloyd AR, Jagger E, Post JJ, Crooks LA, Rawlinson WD, Hahn YS, et al. Host and viral factors in the immunopathogenesis of primary hepatitis C virus infection. Immunol Cell Biol. 2007;85:24–32
  35. Liu R, Paxton WA, Choe S, Ceradini D, Martin SR, Horuk R, et al. Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection. Cell. 1996;86:367–377
  36. Samson M, Libert F, Doranz BJ, Rucker J, Liesnard C, Farber CM, et al. Resistance to HIV-1 infection in caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene. Nature. 1996;382:722–725
  37. Dean M, Carrington M, Winkler C, Huttley GA, Smith MW, Allikmets R, et al. Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Science. 1996;273:1856–1862
  38. Hellier S, Frodsham AJ, Hennig BJ, Klenerman P, Knapp S, Ramaley P, et al. Association of genetic variants of the chemokine receptor CCR5 and its ligands, RANTES and MCP-2, with outcome of HCV infection. Hepatology. 2003;38:1468–1476
  39. Dolan MJ, Kulkarni H, Camargo JF, He W, Smith A, Anaya JM, et al. CCL3L1 and CCR5 influence cell-mediated immunity and affect HIV-AIDS pathogenesis via viral entry-independent mechanisms. Nat Immunol. 2007;8:1324–1336
  40. Woitas RP, Lechmann M, Jung G, Kaiser R, Sauerbruch T, Spengler U. CD30 induction and cytokine profiles in hepatitis C virus core-specific peripheral blood T lymphocytes. J Immunol. 1997;159:1012–1018
  41. Lechner F, Gruener NH, Urbani S, Uggeri J, Santantonio T, Kammer AR, et al. CD8+ T lymphocyte responses are induced during acute hepatitis C virus infection but are not sustained. Eur J Immunol. 2000;30:2479–2487
  42. Loetscher P, Uguccioni M, Bordoli L, Baggiolini M, Moser B, Chizzolini C, et al. CCR5 is characteristic of Th1 lymphocytes. Nature. 1998;391:344–345
  43. Shields PL, Morland CM, Salmon M, Qin S, Hubscher SG, Adams DH. Chemokine and chemokine receptor interactions provide a mechanism for selective T cell recruitment to specific liver compartments within hepatitis C-infected liver. J Immunol. 1999;163:6236–6243
  44. Gruener NH, Lechner F, Jung MC, Diepolder H, Gerlach T, Lauer G, et al. Sustained dysfunction of antiviral CD8+ T lymphocytes after infection with hepatitis C virus. J Virol. 2001;75:5550–5558
  45. Yonekura K, Ichida T, Sato K, Yamagiwa S, Uchida M, Sugahara S, et al. Liver-infiltrating CD56 positive T lymphocytes in hepatitis C virus infection. Liver. 2000;20:357–365
  46. Leroy V, Vigan I, Mosnier JF, Dufeu-Duchesne T, Pernollet M, Zarski JP, et al. Phenotypic and functional characterization of intrahepatic T lymphocytes during chronic hepatitis C. Hepatology. 2003;38:829–841
  47. Goulding C, McManus R, Murphy A, MacDonald G, Barrett S, Crowe J, et al. The CCR5-Delta32 mutation: impact on disease outcome in individuals with hepatitis C infection from a single source. Gut. 2005;54:1157–1161
  48. Goldstein DB. Common genetic variation and human traits. N Engl J Med. 2009;360:1696–1698

PII: S0168-8278(09)00725-9

doi: 10.1016/j.jhep.2009.11.001

Journal of Hepatology
Volume 52, Issue 2 , Pages 153-159 , February 2010

Article Tools

* Image Usage & Resolution